Lv4
566 积分 2022-10-18 加入
The peroxisome: an up-and-coming organelle in immunometabolism
1个月前
已完结
Exploiting temporal aspects of cancer immunotherapy
1个月前
已完结
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer
1个月前
已完结
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
1个月前
已完结
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4
1个月前
已完结
Mechanisms of cancer cell death induction by paclitaxel: an updated review
1个月前
已完结
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
1个月前
已完结
Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
1个月前
已完结
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
1个月前
已完结
Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
1个月前
已完结
皖公网安备34019202002308
